Confirmed: Covid-19 vaccine response depends on our genes
New research has revealed that the efficacy of the Covid-19 vaccine depends on our genome
Haemophilia: Have we found a cure?
A new gene therapy for treating this rare condition has shown success at clinical trial
The potential of polygenic risk scores for prostate cancer
We look at new research that introduces a genetic risk scoring system for the triage of prostate cancer patients in primary care
New sex-specific genetic indicators found in Alzheimer's disease
Researchers have identified new variants in the MGMT gene that increase an individual’s chance of developing Alzheimer's disease, but only in women
The mysterious rise of hepatitis: Could genes be to blame?
An unexpected virus and genomic variant combination has been linked to a rise in hepatitis cases in children
Reducing stroke risk with a genetic test
NHS Tayside introduces the UK's first routine genetic test for stroke patients, estimated to bring improved outcomes to thousands of patients each year
Bowel cancer: What role do our genes play?
We examine two genetically inherited syndromes that increase our risk of colorectal cancer
'Transformational' cardiomyopathy treatment receives funding
We explore a recently funded heart muscle disease project that will use RNA therapy and gene editing in tandem
Under the radar: Exploring clonal haematopoiesis
We investigate genomics’ role in the prevalence of CH and the difference early diagnosis could make
Bringing whole genome sequencing to primary care
We explore how first-contact care and genomic testing could align, and the pivotal part this combination could play in the future
Detecting cancer predisposition: Finding the balance
This week, we weigh up the potential advantages and challenges of wider genomic testing for identifying cancer
Endometriosis and ovarian cancer: A genetic link
A new study aims to unravel the genomic connection between these two different health conditions